AbbVie
2 stories
-
healthNHS Greenlights Revolutionary Ovarian Cancer Drug After Two-Decade Hiatus
NHS approves AbbVie's targeted therapy mirvetuximab soravtansine for platinum resistant ovarian cancer, extending survival and marking the first new treatment in 20 years.
-
sportsAbbVie Partners with MLB to Fight Cancer Through Historic Sponsorship
AbbVie becomes MLB's first official pharmaceutical partner, launching a nationwide 'Striking Out Cancer' campaign tied to strikeouts and cancer donations.